BioLife Solutions Inc (BLFS)
21.96
-0.01
(-0.05%)
USD |
NASDAQ |
May 17, 16:00
21.94
-0.02
(-0.07%)
After-Hours: 20:00
BioLife Solutions Cash from Financing (Quarterly): -0.952M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.952M |
| December 31, 2023 | 9.841M |
| September 30, 2023 | 0.608M |
| June 30, 2023 | 0.704M |
| March 31, 2023 | -0.562M |
| December 31, 2022 | -0.625M |
| September 30, 2022 | 17.41M |
| June 30, 2022 | -0.289M |
| March 31, 2022 | -0.181M |
| December 31, 2021 | -2.105M |
| September 30, 2021 | -1.058M |
| June 30, 2021 | -0.831M |
| March 31, 2021 | 1.216M |
| December 31, 2020 | 1.272M |
| September 30, 2020 | 80.58M |
| June 30, 2020 | 19.73M |
| March 31, 2020 | 0.492M |
| December 31, 2019 | 0.267M |
| September 30, 2019 | 0.743M |
| June 30, 2019 | 0.409M |
| March 31, 2019 | 0.177M |
| December 31, 2018 | -2.148M |
| September 30, 2018 | 22.68M |
| June 30, 2018 | 7.593M |
| March 31, 2018 | 0.018M |
| Date | Value |
|---|---|
| December 31, 2017 | 3.082M |
| September 30, 2017 | 0.4548M |
| June 30, 2017 | 0.1687M |
| March 31, 2017 | 1.091M |
| December 31, 2016 | 0.975M |
| September 30, 2016 | 1.127M |
| June 30, 2016 | 1.053M |
| March 31, 2016 | 0.0121M |
| December 31, 2015 | 0.2688M |
| September 30, 2015 | 0.02M |
| June 30, 2015 | 0.055M |
| March 31, 2015 | 0.0249M |
| December 31, 2014 | 0.003M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.0806M |
| March 31, 2014 | 13.60M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.025M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.0255M |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.30M |
| March 31, 2012 | 0.175M |
| December 31, 2011 | 0.225M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.105M
Minimum
Dec 2021
80.58M
Maximum
Sep 2020
6.334M
Average
0.4505M
Median
Cash from Financing (Quarterly) Benchmarks
| Align Technology Inc | -11.72M |
| ThermoGenesis Holdings Inc | 0.217M |
| NeuroOne Medical Technologies Corp | 1.205M |
| SINTX Technologies Inc | 5.328M |
| Nutriband Inc | -0.005M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.475M |
| Cash from Investing (Quarterly) | -0.221M |
| Free Cash Flow | -17.70M |
| Free Cash Flow Per Share (Quarterly) | -0.1063 |
| Free Cash Flow to Equity (Quarterly) | -3.987M |
| Free Cash Flow to Firm (Quarterly) | -4.621M |
| Free Cash Flow Yield | -1.82% |